Effector mechanisms by which adoptively transferred T cells promote tumor eradication.
作者信息
Greenberg P D, Kern D E, Jensen M C, Klarnet J P, Cheever M A
机构信息
University of Washington, Division of Oncology, Seattle.
出版信息
Prog Clin Biol Res. 1987;244:127-35.
PMID:2958868
Abstract
摘要
相似文献
1
Effector mechanisms by which adoptively transferred T cells promote tumor eradication.
Prog Clin Biol Res. 1987;244:127-35.
2
3
Cloned helper and cytotoxic T lymphocytes as effector cells in adoptive immunotherapy of murine leukemia.克隆的辅助性和细胞毒性T淋巴细胞作为小鼠白血病过继免疫治疗中的效应细胞。
Prog Clin Biol Res. 1989;288:141-9.
4
5
Treatment of established tumor by adoptive immunotherapy with specifically immune T cells.采用特异性免疫T细胞进行过继性免疫疗法治疗已形成的肿瘤。
Surv Immunol Res. 1985;4(4):283-96.
6
Specific adoptive immunotherapy.
Prog Clin Biol Res. 1989;288:349-61.
7
8
Effector mechanisms operative in adoptive therapy of tumor-bearing animals: implications for the use of interleukin-2.荷瘤动物过继性治疗中的效应机制：白细胞介素-2应用的意义
J Biol Response Mod. 1984 Oct;3(5):455-61.
9
引用本文的文献
1
Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset.非细胞溶解性Lyt-2+ T细胞亚群识别肿瘤抗原及介导抗肿瘤效应的机制。
Jpn J Cancer Res. 1988 Jan;79(1):99-108. doi: 10.1111/j.1349-7006.1988.tb00016.x.
2
Mediation of in vivo tumor-neutralizing activity by Lyt-2+ as well as L3T4+ T cell subsets.Lyt-2+以及L3T4+ T细胞亚群对体内肿瘤中和活性的介导作用。
Jpn J Cancer Res. 1988 Jan;79(1):91-8. doi: 10.1111/j.1349-7006.1988.tb00015.x.
3
Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cells.重组人肿瘤坏死因子通过Lyt-2+细胞在体内介导小鼠肉瘤消退。
Cancer Immunol Immunother. 1989;28(2):153-6. doi: 10.1007/BF00199117.
Zotero 插件